Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 4;32(5):107999.
doi: 10.1016/j.celrep.2020.107999.

Structural and Mechanistic Regulation of the Pro-degenerative NAD Hydrolase SARM1

Affiliations
Free article

Structural and Mechanistic Regulation of the Pro-degenerative NAD Hydrolase SARM1

Matthew Bratkowski et al. Cell Rep. .
Free article

Abstract

The NADase SARM1 is a central switch in injury-activated axon degeneration, an early hallmark of many neurological diseases. Here, we present cryo-electron microscopy (cryo-EM) structures of autoinhibited (3.3 Å) and active SARM1 (6.8 Å) and provide mechanistic insight into the tight regulation of SARM1's function by the local metabolic environment. Although both states retain an octameric core, the defining feature of the autoinhibited state is a lock between the autoinhibitory Armadillo/HEAT motif (ARM) and catalytic Toll/interleukin-1 receptor (TIR) domains, which traps SARM1 in an inactive state. Mutations that break this lock activate SARM1, resulting in catastrophic neuronal death. Notably, the mutants cannot be further activated by the endogenous activator nicotinamide mononucleotide (NMN), and active SARM1 is product inhibited by Nicotinamide (NAM), highlighting SARM1's functional dependence on key metabolites in the NAD salvage pathway. Our studies provide a molecular understanding of SARM1's transition from an autoinhibited to an injury-activated state and lay the foundation for future SARM1-based therapies to treat axonopathies.

Keywords: NAD hydrolase; NAM; NMN; SARM1; autoinhibition; axon; axonopathies; cryo-EM.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests M.B., D.A.T., S.L., P.M., Y.-S.Y., G.D., T.C.B., J.D., A.C., J.A.K., S.P.B., and S.S. are employees or former employees of Nura Bio and hold Nura Bio stock.

Publication types

LinkOut - more resources